Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Construction and isolation of recombinant MVA.
Methods Mol. Biol. 269, 77-99 (2004)
Modified vaccinia virus Ankara (MVA) is a valuable tool for the expression of recombinant genes used for such purposes as the study of protein functions or characterization of cellular and humoral immune responses. A major advantage of MVA is its clear safety record, and it can be handled under biosafety level 1 conditions. Despite its replication deficiency in human and most mammalian cells, MVA provides high-level gene expression and has proven to be immunogenic when delivering heterologous antigens in animals and humans. This chapter provides state-of-the-art protocols for generation, plaque isolation, molecular characterization, as well as amplification and purification of MVA vector viruses to obtain recombinant viruses for further evaluation.
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Editors
Isaacs, S.N.*
Keywords
poxvirus; modified vaccinia virus Ankara (MVA); recombinant vaccine
ISSN (print) / ISBN
1064-3745
e-ISSN
1940-6029
Conference Title
Vaccinia Virus and Poxvirology: Methods and Protocols
Journal
Methods in Molecular Biology
Quellenangaben
Volume: 269,
Pages: 77-99
Series
Methods in Molecular Biology
Publisher
Springer
Publishing Place
Berlin [u.a.]
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Virology (VIRO)